SCHEMBL4876904

SCHEMBL4876904

CCCCCCCCCNC(=O)C(O)c1ccc(O)c(OC)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.59
BLM P54132 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TSHR P16473 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5705007 1.00 NAAA (0.59) NAAABLMNPSR1TSHR
SCHEMBL2121870 1.00 NAAA (0.59) NAAABLMNPSR1TSHR
SCHEMBL5704957 0.90 NAAA (0.59) NAAA
SCHEMBL4881044 0.90 NAAA (0.59) NAAA
SCHEMBL4886844 0.90 NAAA (0.59) NAAA
SCHEMBL4878748 0.88 TSHR (0.55) BLMNPSR1TSHR
SCHEMBL10876855 0.88
SCHEMBL7084564 0.86 NAAA (0.66) NAAANPSR1
SCHEMBL4878027 0.86 NAAA (0.66) NAAANPSR1
SCHEMBL10607817 0.82 TRPV1 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515943-B1 USE OF ALKYLAMIDOMANDELATES AS FLAVOURINGS SYMRISE GMBH & CO KG (DE) 2006-08-30 EP claimed
US-20050208084-A1 Use of alkylamidomandelates as flavourings SYMRISE GMBH & CO. KG (DE) 2005-09-22 US claimed
US-20080038386-A1 Use of a liquid cooling sensate to provide a pungent, warming or tingling sensate composition MOZA ASHOK K 2008-02-14 US disclosed
US-20050208084-A1 Use of alkylamidomandelates as flavourings SYMRISE GMBH & CO. KG (DE) 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050208084-A1 Use of alkylamidomandelates as flavourings HNMT, TAS2R7, PNMT NAAA 4/4885BLM 3923/4885NPSR1 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.